The mechanism of 2-chlorodeoxyadenosine-induced cell death. 1989

Y Wataya, and Y Hirota, and A Hiramoto-Yoshioka, and S Tanaka, and T Otani, and J Minowada, and A Matsuda, and T Ueda
Faculty of Pharmaceutical Sciences, Okayama University, Japan.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D003513 Cycloheximide Antibiotic substance isolated from streptomycin-producing strains of Streptomyces griseus. It acts by inhibiting elongation during protein synthesis. Actidione,Cicloheximide
D003839 Deoxyadenosines Adenosine molecules which can be substituted in any position, but are lacking one hydroxyl group in the ribose part of the molecule. Adenine Deoxyribonucleosides,Adenylyldeoxyribonucleosides,Deoxyadenosine Derivatives,Deoxyribonucleosides, Adenine,Derivatives, Deoxyadenosine
D003841 Deoxycytidine A nucleoside component of DNA composed of CYTOSINE and DEOXYRIBOSE. Cytosine Deoxyribonucleoside,Cytosine Deoxyriboside,Deoxyribonucleoside, Cytosine,Deoxyriboside, Cytosine
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D015762 2-Chloroadenosine 2-Chloroadenosine. A metabolically stable analog of adenosine which acts as an adenosine receptor agonist. The compound has a potent effect on the peripheral and central nervous system. 2 Chloroadenosine

Related Publications

Y Wataya, and Y Hirota, and A Hiramoto-Yoshioka, and S Tanaka, and T Otani, and J Minowada, and A Matsuda, and T Ueda
October 1995, The Biochemical journal,
Y Wataya, and Y Hirota, and A Hiramoto-Yoshioka, and S Tanaka, and T Otani, and J Minowada, and A Matsuda, and T Ueda
September 1994, Annals of internal medicine,
Y Wataya, and Y Hirota, and A Hiramoto-Yoshioka, and S Tanaka, and T Otani, and J Minowada, and A Matsuda, and T Ueda
January 1991, Advances in experimental medicine and biology,
Y Wataya, and Y Hirota, and A Hiramoto-Yoshioka, and S Tanaka, and T Otani, and J Minowada, and A Matsuda, and T Ueda
January 1994, Advances in experimental medicine and biology,
Y Wataya, and Y Hirota, and A Hiramoto-Yoshioka, and S Tanaka, and T Otani, and J Minowada, and A Matsuda, and T Ueda
January 1984, Advances in experimental medicine and biology,
Y Wataya, and Y Hirota, and A Hiramoto-Yoshioka, and S Tanaka, and T Otani, and J Minowada, and A Matsuda, and T Ueda
October 1992, Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses,
Y Wataya, and Y Hirota, and A Hiramoto-Yoshioka, and S Tanaka, and T Otani, and J Minowada, and A Matsuda, and T Ueda
January 1993, Cancer investigation,
Y Wataya, and Y Hirota, and A Hiramoto-Yoshioka, and S Tanaka, and T Otani, and J Minowada, and A Matsuda, and T Ueda
January 1994, Annals of internal medicine,
Y Wataya, and Y Hirota, and A Hiramoto-Yoshioka, and S Tanaka, and T Otani, and J Minowada, and A Matsuda, and T Ueda
March 1997, Leukemia & lymphoma,
Y Wataya, and Y Hirota, and A Hiramoto-Yoshioka, and S Tanaka, and T Otani, and J Minowada, and A Matsuda, and T Ueda
January 2000, Methods in enzymology,
Copied contents to your clipboard!